← Back to Search

Nonsteroidal Anti-inflammatory Drug (NSAID)

The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine

Phase 3
Waitlist Available
Led By Caren Behar, MD
Research Sponsored by Behar, Caren, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
All Individual Drugs Already Approved
Approved for 5 Other Conditions
Pivotal Trial

Summary

This trial is testing a mouth-applied pain reliever called ketoprofen to see if it helps people with sudden migraine attacks. The goal is to find out if it works well and is safe to use. Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that has been tested in various formulations for the treatment of acute migraine attacks.

Eligible Conditions
  • Migraine

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Topical, intra-oral ketoprofen gelActive Control1 Intervention
Group II: Placebo gelPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Behar, Caren, M.D.Lead Sponsor
1 Previous Clinical Trials
67 Total Patients Enrolled
1 Trials studying Migraine
67 Patients Enrolled for Migraine
Caren Behar, MDPrincipal InvestigatorNew York Medical College
1 Previous Clinical Trials
67 Total Patients Enrolled
1 Trials studying Migraine
67 Patients Enrolled for Migraine
~7 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top